• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1200615 左乙拉西坦注射液 levetiracetam Injection Chemical Drugs(3.1) New Drug Application 2013-08-19 陕西天森药物研究开发有限公司 Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd Certificate Issued 2016-01-14 view
CXHB1300019 左乙拉西坦注射液 levetiracetam Injection Chemical Drugs Supplementary Application 2013-08-19 陕西天森药物研究开发有限公司 Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd Approval Completed-Pending Certificated 2015-12-14 view
CXHL1100814 丙戊酸半钠缓释片 divalproex sodium Tablet, extended release Chemical Drugs(3.1) New Drug Application 2012-04-27 陕西天森药物研究开发有限公司 Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd Certificate Issued 2015-08-21 view
CXHL0800435 双丙戊酸钠 divalproex sodium Active ingredient Chemical Drugs(3.1) New Drug Application 2008-11-26 陕西天森药物研究开发有限公司 Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd Certificate Issued 2010-04-14 view
CXHL0800434 双丙戊酸钠肠溶片 divalproex sodium Tablet Chemical Drugs(3.1) New Drug Application 2008-11-26 陕西天森药物研究开发有限公司 Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd Certificate Issued 2010-04-01 view